Arden Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $701K | Sell |
2,244
-2
| -0.1% | -$588 | 0.1% | 115 |
|
|
2024
Q1 | $639K | Sell |
2,246
-61
| -3% | -$17.8K | 0.09% | 127 |
|
|
2023
Q4 | $664K | Sell |
2,307
-24
| -1% | -$6.54K | 0.1% | 124 |
|
|
2023
Q3 | $626K | Sell |
2,331
-12
| -0.5% | -$3K | 0.1% | 121 |
|
|
2023
Q2 | $520K | Sell |
2,343
-837
| -26% | -$194K | 0.09% | 142 |
|
|
2023
Q1 | $769K | Sell |
3,180
-114
| -3% | -$28K | 0.14% | 127 |
|
|
2022
Q4 | $865K | Sell |
3,294
-161
| -5% | -$43.2K | 0.18% | 118 |
|
|
2022
Q3 | $778K | Sell |
3,455
-98
| -3% | -$23.8K | 0.2% | 117 |
|
|
2022
Q2 | $864K | Sell |
3,553
-140
| -4% | -$34.3K | 0.2% | 119 |
|
|
2022
Q1 | $893K | Sell |
3,693
-251
| -6% | -$57.7K | 0.17% | 122 |
|
|
2021
Q4 | $887K | Sell |
3,944
-49
| -1% | -$10.3K | 0.15% | 141 |
|
|
2021
Q3 | $849K | Sell |
3,993
-3,457
| -46% | -$796K | 0.15% | 144 |
|
|
2021
Q2 | $1.82M | Sell |
7,450
-1,333
| -15% | -$328K | 0.3% | 71 |
|
|
2021
Q1 | $2.19M | Sell |
8,783
-707
| -7% | -$169K | 0.37% | 54 |
|
|
2020
Q4 | $2.18M | Sell |
9,490
-97
| -1% | -$22.4K | 0.36% | 51 |
|
|
2020
Q3 | $2.44M | Buy |
9,587
+768
| +9% | +$190K | 0.44% | 41 |
|
|
2020
Q2 | $2.08M | Buy |
8,819
+436
| +5% | +$99.5K | 0.38% | 50 |
|
|
2020
Q1 | $1.7M | Buy |
8,383
+2,160
| +35% | +$472K | 0.34% | 60 |
|
|
2019
Q4 | $1.5M | Sell |
6,223
-338
| -5% | -$74.5K | 0.24% | 91 |
|
|
2019
Q3 | $1.27M | Sell |
6,561
-429
| -6% | -$82.3K | 0.21% | 108 |
|
|
2019
Q2 | $1.29M | Sell |
6,990
-1,047
| -13% | -$187K | 0.22% | 100 |
|
|
2019
Q1 | $1.53M | Sell |
8,037
-366
| -4% | -$69.9K | 0.25% | 88 |
|
|
2018
Q4 | $1.64M | Buy |
8,403
+140
| +2% | +$27.3K | 0.29% | 71 |
|
|
2018
Q3 | $1.71M | Buy |
8,263
+614
| +8% | +$121K | 0.27% | 77 |
|
|
2018
Q2 | $1.41M | Sell |
7,649
-1,435
| -16% | -$254K | 0.22% | 98 |
|
|
2018
Q1 | $1.55M | Sell |
9,084
-383
| -4% | -$70.3K | 0.24% | 88 |
|
|
2017
Q4 | $1.65M | Sell |
9,467
-376
| -4% | -$66.5K | 0.25% | 86 |
|
|
2017
Q3 | $1.83M | Sell |
9,843
-537
| -5% | -$95.1K | 0.28% | 72 |
|
|
2017
Q2 | $1.79M | Sell |
10,380
-198
| -2% | -$32.2K | 0.27% | 75 |
|
|
2017
Q1 | $1.74M | Buy |
10,578
+910
| +9% | +$151K | 0.27% | 76 |
|
|
2016
Q4 | $1.41M | Sell |
9,668
-159
| -2% | -$23.9K | 0.21% | 99 |
|
|
2016
Q3 | $1.64M | Sell |
9,827
-20,521
| -68% | -$3.47M | 0.25% | 84 |
|
|
2016
Q2 | $4.62K | Sell |
30,348
-916
| -3% | -$142K | 0.35% | 73 |
|
|
2016
Q1 | $4.69M | Buy |
31,264
+5,510
| +21% | +$819K | 0.37% | 70 |
|
|
2015
Q4 | $4.18M | Buy |
25,754
+1,233
| +5% | +$194K | 0.35% | 69 |
|
|
2015
Q3 | $3.39M | Buy |
24,521
+8,496
| +53% | +$1.34M | 0.28% | 92 |
|
|
2015
Q2 | $2.46K | Buy |
16,025
+182
| +1% | +$29.2K | 0.37% | 65 |
|
|
2015
Q1 | $2.53K | Buy |
15,843
+4,756
| +43% | +$749K | 0.37% | 65 |
|
|
2014
Q4 | $1.77M | Sell |
11,087
-5,392
| -33% | -$840K | 0.24% | 89 |
|
|
2014
Q3 | $2.31M | Buy |
16,479
+840
| +5% | +$110K | 0.32% | 64 |
|
|
2014
Q2 | $1.85M | Buy |
15,639
+3,615
| +30% | +$418K | 0.25% | 85 |
|
|
2014
Q1 | $1.48M | Sell |
12,024
-2,157
| -15% | -$262K | 0.18% | 105 |
|
|
2013
Q4 | $1.62M | Sell |
14,181
-868
| -6% | -$98.7K | 0.2% | 96 |
|
|
2013
Q3 | $1.69M | Sell |
15,049
-4,640
| -24% | -$503K | 0.22% | 84 |
|
|
2013
Q2 | $1.94M | Buy |
+19,689
| New | +$2.04M | 0.24% | 83 |
|
Other funds holding AMGN
Arden Trust's AMGN Position: Q2 2024 in Review
Arden Trust reduced its Amgen (AMGN) stake by 0.09% in Q2 2024, selling an estimated $588 and leaving 2,244 shares worth $701K. The position accounts for 0.1% of the portfolio, ranked #115.
Arden Trust first reported a position in AMGN in Q2 2013 and has held it in 45 quarters since. The position peaked at $4.69M in Q1 2016. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.
- Arden Trust held 2,244 shares of Amgen worth $701K as of Q2 2024.
- Arden Trust sold 2 Amgen shares in Q2 2024, an estimated $588.
- Amgen made up 0.1% of Arden Trust's portfolio in Q2 2024, its #115 holding.
- Arden Trust first reported a position in Amgen in Q2 2013 and has held it in 45 quarters since.
- Arden Trust's Amgen position peaked at $4.69M in Q1 2016.
- 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.
Based on Arden Trust's 13F filing for Q2 2024, filed 9 Jul 2024.